Efficacy of Erlotinib as salvage treatment in patients with pulmonary adenocarcinoma with disease progression after previous EGFR-TKI treatment
Latest Information Update: 29 Aug 2017
At a glance
- Drugs Erlotinib (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer
- Focus Therapeutic Use
- 29 Aug 2017 New trial record